Lack of BRAF mutations in hyalinizing trabecular neoplasm

26Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The hyalinizing trabecular neoplasm (HTN) of the thyroid is an unusual and controversial lesion. Some consider it a peculiar type of papillary thyroid carcinoma (PTC) because of its nuclear features and presence of psammoma bodies. Others consider it an adenoma. Molecular studies have found RET/PTC translocations in some examples, supporting HTN as a PTC; however mutations in BRAF (another marker for PTC) have not been found. We report two cases of classic HTN and a case of trabecular PTC and show BRAF mutations in the latter and not in HTN. Trabecular growth pattern is insufficient for a diagnosis of HTN and lesions with such a pattern and nuclear features of PTC are cancers. Morphologically classic HTN are not associated with metastatic potential and should be considered adenomas. © 2006 Baloch et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Baloch, Z. W., Puttaswamy, K., Brose, M., & LiVolsi, V. A. (2006). Lack of BRAF mutations in hyalinizing trabecular neoplasm. CytoJournal, 3. https://doi.org/10.1186/1742-6413-3-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free